Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer Res. 2016 Nov 18;77(3):672–683. doi: 10.1158/0008-5472.CAN-16-1765

Figure 3. TAS secretory response is specific to TLR4 and TLR5 stimulation.

Figure 3

A and B, IL6 and IL8 expression in TAS exposed to 100 ng/ml of the indicated pattern recognition receptor (PRR) agonists. C and D, TAS expression of IL6 and IL8 following exposure to ultrapure LPS at the indicated doses. Bars represent mean ± S.E.M. *P < 0.05 compared to controls using the independent samples t test.